These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34702088)

  • 1. The estimand framework and its application in substance use disorder clinical trials: a case study.
    Roydhouse JK; Floden L; Tomko RL; Gray KM; Bell ML
    Am J Drug Alcohol Abuse; 2021 Nov; 47(6):658-663. PubMed ID: 34702088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating estimands into clinical trial statistical analysis plans.
    Kang M; Kendall MA; Ribaudo H; Tierney C; Zheng L; Smeaton L; Lindsey JC
    Clin Trials; 2022 Jun; 19(3):285-291. PubMed ID: 35257600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimands for clinical endpoints in tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
    Weir IR; Dufault SM; Phillips PPJ
    Trials; 2024 Mar; 25(1):180. PubMed ID: 38468320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
    Weir IR; Dufault SM; Phillips PP
    Res Sq; 2023 Nov; ():. PubMed ID: 37986887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimands in hematologic oncology trials.
    Sun S; Weber HJ; Butler E; Rufibach K; Roychoudhury S
    Pharm Stat; 2021 Jul; 20(4):793-805. PubMed ID: 33686762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimands and Complex Innovative Designs.
    Collignon O; Schiel A; Burman CF; Rufibach K; Posch M; Bretz F
    Clin Pharmacol Ther; 2022 Dec; 112(6):1183-1190. PubMed ID: 35253205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimand framework: Delineating what to be estimated with clinical questions of interest in clinical trials.
    Jin M; Liu G
    Contemp Clin Trials; 2020 Sep; 96():106093. PubMed ID: 32777382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
    Mehrotra DV
    Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimands in published protocols of randomised trials: urgent improvement needed.
    Kahan BC; Morris TP; White IR; Carpenter J; Cro S
    Trials; 2021 Oct; 22(1):686. PubMed ID: 34627347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining estimands using a mix of strategies to handle intercurrent events in clinical trials.
    Qu Y; Shurzinske L; Sethuraman S
    Pharm Stat; 2021 Mar; 20(2):314-323. PubMed ID: 33098267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimands: A More Strategic Approach to Study Design and Analysis.
    Akacha M; Kothny W
    Clin Pharmacol Ther; 2017 Dec; 102(6):894-896. PubMed ID: 29119556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimands for overall survival in clinical trials with treatment switching in oncology.
    Manitz J; Kan-Dobrosky N; Buchner H; Casadebaig ML; Degtyarev E; Dey J; Haddad V; Jie F; Martin E; Mo M; Rufibach K; Shentu Y; Stalbovskaya V; Sammi Tang R; Yung G; Zhou J
    Pharm Stat; 2022 Jan; 21(1):150-162. PubMed ID: 34605168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the Estimand Framework to Anesthesia Trials.
    De Silva AP; Leslie K; Braat S; Grobler AC
    Anesthesiology; 2024 Jul; 141(1):13-23. PubMed ID: 38743905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimands in practice: Bridging the gap between study objectives and statistical analysis.
    Phillips A; Clark T
    Pharm Stat; 2021 Jan; 20(1):68-76. PubMed ID: 32893473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handling Missing Data and Drop Out in Hospice/Palliative Care Trials Through the Estimand Framework.
    Grobler AC; Lee KJ; Wong A; Currow DC; Braat S
    J Pain Symptom Manage; 2022 Apr; 63(4):e431-e439. PubMed ID: 34954068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimands for factorial trials.
    Kahan BC; Morris TP; Goulão B; Carpenter J
    Stat Med; 2022 Sep; 41(22):4299-4310. PubMed ID: 35751568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.
    Rehal S; Cro S; Phillips PP; Fielding K; Carpenter JR
    Clin Trials; 2023 Oct; 20(5):497-506. PubMed ID: 37277978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.
    Mitroiu M; Teerenstra S; Oude Rengerink K; Pétavy F; Roes KCB
    Pharm Stat; 2022 Sep; 21(5):1037-1057. PubMed ID: 35678545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.